Is Garlic Cognition Randomized Trial safe?

Updated August 2026

Quick Answer

Garlic Cognition Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines.

Key Takeaways

  • 01The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines. [Deshmukh S (2025)]
  • 02Result A total of 44 studies was included in the systematic review, and ten RCTs involving 524 participants were included in the meta-analysis. [Deshmukh S (2025)]
  • 03Conclusion This systematic review shows that although Ayurvedic interventions do not achieve significant BP reductions versus conventional treatments, they may provide clinical benefits with good safety. [Deshmukh S (2025)]
  • 04Background Essential hypertension (EH) is a major contributor to cardiovascular morbidity and mortality that has become a public health challenge owing to poor control and adherence. [Deshmukh S (2025)]
The current Migaku evidence database contains 2 reusable source documents for Garlic Cognition Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines. [Deshmukh S (2025); evidence level 1] - Result A total of 44 studies was included in the systematic review, and ten RCTs involving 524 participants were included in the meta-analysis. [Deshmukh S (2025); evidence level 1] - Conclusion This systematic review shows that although Ayurvedic interventions do not achieve significant BP reductions versus conventional treatments, they may provide clinical benefits with good safety. [Deshmukh S (2025); evidence level 1] - Background Essential hypertension (EH) is a major contributor to cardiovascular morbidity and mortality that has become a public health challenge owing to poor control and adherence. [Deshmukh S (2025); evidence level 1] - These changes likely contribute to cognitive decline, sensorimotor impairments and increased vulnerability to neurodegenerative disorders (). [Mony Tamanna (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effectiveness and safety of Ayurvedic intervention in essential hypertension: a systematic review with meta-analysis.
  2. Supplementation of aged garlic extract attenuates age-associated memory impairment and cognitive decline: Involvement of molecular pathways in the cortex and hippocampus